Avenue Therapeutics, Inc. (ATXI) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1240917,
    "name": "Avenue Therapeutics, Inc.",
    "stock_name": "Avenue Therapeutics, Inc.",
    "full_name": "Avenue Therapeutics, Inc.",
    "name_url": "stocks-analysis/avenue-therapeutics-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "0.80",
    "chg": -0.09,
    "chgp": "-10.46%",
    "dir": -1,
    "prev_price": "0.89",
    "mcapval": "2.33",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US05360L3042",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "4.15 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/avenue-therapeutics-inc-1240917-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Avenue Therapeutics, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-avenue-therapeutics-inc-technically-bullish-or-bearish-3547636",
        "imagepath": "",
        "date": "2025-09-20 19:59:43",
        "description": "As of 10 September 2025, the technical trend for Avenue Therapeutics, Inc. has changed from sideways to mildly bullish. The weekly MACD and KST indicators are both mildly bullish, while the monthly MACD and KST also indicate mild bullishness. However, the weekly RSI is bearish, and the daily moving averages are mildly bearish. The Bollinger Bands show a bullish stance on the weekly but are mildly bearish on the monthly. According to Dow Theory, there is no trend on the weekly but a mild bullish trend on the monthly.\n\nIn terms of performance, the stock has significantly underperformed the S&P 500 over the past year, with a return of -68.52% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD, KST, and Bollinger Bands, despite some bearish signals from the RSI and moving averages...."
      },
      {
        "title": "Is Avenue Therapeutics, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-avenue-therapeutics-inc-overvalued-or-undervalued-3543949",
        "imagepath": "",
        "date": "2025-09-20 18:33:28",
        "description": "As of 14 August 2025, the valuation grade for Avenue Therapeutics, Inc. has moved from does not qualify to risky, indicating a significant downgrade in its investment appeal. The company appears to be overvalued, given its negative financial metrics, including a Price to Book Value of 0.24 and an EV to EBITDA ratio of 0.28. Additionally, the Return on Equity (ROE) is alarmingly low at -393.59%, highlighting severe profitability issues.\n\nIn comparison to its peers, Avenue Therapeutics has a P/E ratio of -0.3745, while Fresh Tracks Therapeutics, Inc. has a P/E of 0.8418, indicating that Avenue is lagging behind in valuation metrics. Furthermore, Pulmatrix, Inc. shows a more negative EV to EBITDA ratio of -1.4762, suggesting that Avenue's valuation is less favorable in the context of its industry. Notably, the company's stock has underperformed significantly, with a year-to-date return of -57.50% compared to t..."
      }
    ],
    "total": 6,
    "sid": "1240917",
    "stock_news_url": "https://www.marketsmojo.com/news/avenue-therapeutics-inc-1240917"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Avenue Therapeutics, Inc. technically bullish or bearish?

2025-09-20 19:59:43

As of 10 September 2025, the technical trend for Avenue Therapeutics, Inc. has changed from sideways to mildly bullish. The weekly MACD and KST indicators are both mildly bullish, while the monthly MACD and KST also indicate mild bullishness. However, the weekly RSI is bearish, and the daily moving averages are mildly bearish. The Bollinger Bands show a bullish stance on the weekly but are mildly bearish on the monthly. According to Dow Theory, there is no trend on the weekly but a mild bullish trend on the monthly. In terms of performance, the stock has significantly underperformed the S&P 500 over the past year, with a return of -68.52% compared to the S&P 500's 17.14%. Overall, the current technical stance is mildly bullish, driven primarily by the weekly MACD, KST, and Bollinger Bands, despite some bearish signals from the RSI and moving averages....

Is Avenue Therapeutics, Inc. overvalued or undervalued?

2025-09-20 18:33:28

As of 14 August 2025, the valuation grade for Avenue Therapeutics, Inc. has moved from does not qualify to risky, indicating a significant downgrade in its investment appeal. The company appears to be overvalued, given its negative financial metrics, including a Price to Book Value of 0.24 and an EV to EBITDA ratio of 0.28. Additionally, the Return on Equity (ROE) is alarmingly low at -393.59%, highlighting severe profitability issues. In comparison to its peers, Avenue Therapeutics has a P/E ratio of -0.3745, while Fresh Tracks Therapeutics, Inc. has a P/E of 0.8418, indicating that Avenue is lagging behind in valuation metrics. Furthermore, Pulmatrix, Inc. shows a more negative EV to EBITDA ratio of -1.4762, suggesting that Avenue's valuation is less favorable in the context of its industry. Notably, the company's stock has underperformed significantly, with a year-to-date return of -57.50% compared to t...

View All News